Hutchmed shares slide as recalls cancer treatment Tazverik
9th Mar 2026 10:49
(Alliance News) - Hutchmed China Ltd on Monday saw its shares fall after reporting the withdrawal of a cancer medication which it licenses from Ipsen SA. Read More
| Price | 202.00p on 20-03-2026 at 19:40:06 |
|---|---|
| Change | -1.00p -0.49% |
| Buy | 218.00p |
| Sell | 203.00p |
| Last Trade: | Sell 33.00 at 202.00p |
| Day's Volume: | 6,945 |
| Last Close: | 202.00p |
| Open: | 203.00p |
| ISIN: | KYG4672N1198 |
| Day's Range | 202.00p - 203.00p |
| 52wk Range: | 187.50p - 292.00p |
| Market Capitalisation: | £1.74b |
| VWAP: | 203.49493p |
| Shares in Issue: | 859.52m |
Sector: Medicine and Biotech
Listed In: FTSE AIM 100, FTSE AIM All-Share,
Hutchmed (HCM) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Sell* | 33 | 202.00p | Uncrossing Trade |
16:35:26 - 20-Mar-26 |
| Buy* | 1 | 213.76p | Ordinary |
15:55:10 - 20-Mar-26 |
| Sell* | 85 | 203.40p | Ordinary |
15:42:30 - 20-Mar-26 |
| Sell* | 3 | 203.45p | Ordinary |
15:17:43 - 20-Mar-26 |
| Buy* | 8 | 210.00p | Ordinary |
15:17:43 - 20-Mar-26 |
| Sell* | 105 | 203.64p | Ordinary |
14:54:35 - 20-Mar-26 |
| Sell* | 148 | 203.00p | Automatic Execution |
14:30:16 - 20-Mar-26 |
| Unknown* | 0 | 203.00p | SI Trade |
13:35:10 - 20-Mar-26 |
| Sell* | 3,280 | 204.00p | Ordinary |
12:19:30 - 20-Mar-26 |
| Sell* | 3,280 | 203.00p | Ordinary |
12:19:22 - 20-Mar-26 |
Hutchmed (HCM) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 16th Mar 2026 8:30 am | RNS | Vesting of awards under Long Term Incentive Plan |
| 16th Mar 2026 8:30 am | RNS | Vesting of awards under Long Term Incentive Plan |
| 11th Mar 2026 8:30 am | RNS | Vesting of awards under Long Term Incentive Plan |
| 11th Mar 2026 8:30 am | RNS | Vesting of awards under Long Term Incentive Plan |
| 9th Mar 2026 9:30 am | RNS | Update on Licensed Oncology Product in China |
| 6th Mar 2026 8:30 am | RNS | Directorate change |
| 5th Mar 2026 1:00 pm | RNS-R | Publication of Form 20-F |
| 5th Mar 2026 11:00 am | RNS | 2025 Full Year Results and Business Updates |
| 4th Mar 2026 8:30 am | RNS-R | HUTCHMED Initiates Global Trial of ATTC Candidate |
| 6th Feb 2026 8:30 am | RNS | HUTCHMED to Announce 2025 Final Results |